Balance Sheet

Assets

-47%

-21%

10Y

Currency: KRW

	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	51	206	263	756	806	1 450	1 070	3 031	3 683	7 432	9 603	19 274	15 752	21 124	53 330	59 927	75 170	25 811	40 987
Cash	0	0	0	0	0	0	0	0	1	2	3	2	3	4	1	5	3	2	1
Cash Equivalents	51	206	263	756	806	1 450	1 070	3 031	3 682	7 430	9 600	19 272	15 749	21 120	53 329	59 922	75 167	25 809	40 987
Short-Term Investments	544	500	529	560	1 670	2 838	6 786	2 707	2 135	8 934	3 632	9 062	8 229	11 982	16 239	6 243	8 327	21 540	16 197
Total Receivables	703	998	1 305	1 908	2 770	1 856	2 135	1 418	2 852	3 215	4 292	5 034	5 692	5 057	2 953	12 207	40 641	65 268	2 697
Accounts Receivables	655	923	1 233	1 875	2 734	1 828	2 091	1 392	2 822	3 202	4 127	5 004	5 449	4 987	2 834	11 772	9 789	4 237	2 077
Other Receivables	48	75	72	33	36	28	44	26	30	13	165	30	243	70	119	435	30 852	61 031	620
Inventory	281	339	453	530	526	326	706	991	687	641	952	1 099	1 169	1 461	1 346	1 532	1 002	800	1 011
Other Current Assets	27	39	76	191	322	179	100	115	1 220	795	778	288	259	533	1 419	1 419	373	509	88
Total Current Assets	1 606	2 082	2 626	3 946	6 093	6 650	10 797	8 261	10 578	21 016	19 256	34 757	31 101	40 156	75 287	81 327	125 513	113 928	60 980
PP&E Net	302	1 382	1 298	2 052	2 792	2 603	3 417	3 390	3 372	3 014	6 636	7 753	7 922	7 587	7 550	11 951	13 758	15 031	22 696
PP&E Gross	302	1 382	1 298	2 052	2 792	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	1 668	1 793	1 928	2 104	2 402	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	2 791	2 989	3 299	3 704	3 970	4 091	5 049	6 643	7 645	8 482	9 966	12 297	880	952	1 182	1 135	1 213	1 386	1 405
Goodwill	0	9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Note Receivable	0	0	0	0	0	0	50	50	50	50	0	0	30	30	30	0	0	30	0
Long-Term Investments	0	0	24	91	87	93	124	161	185	311	2 805	2 886	2 430	1 055	1 070	4 151	10 592	9 514	12 784
Other Long-Term Assets	59	125	109	136	124	624	980	1 139	1 377	1 528	1 707	1 912	3 267	5 017	3 913	1 972	2 289	1 070	750
Other Assets	0	9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	4 758 N/A	6 587 +38%	7 357 +12%	9 929 +35%	13 066 +32%	14 062 +8%	20 418 +45%	19 645 -4%	23 207 +18%	34 400 +48%	40 370 +17%	59 606 +48%	45 630 -23%	54 796 +20%	89 032 +62%	100 536 +13%	153 365 +53%	140 959 -8%	98 615 -30%
Liabilities
Accounts Payable	52	116	95	125	157	118	370	159	412	173	559	217	315	161	264	207	561	97	0
Accrued Liabilities	75	91	147	121	190	16	13	7	5	1	4	3	6	5	19	0	2	5	0
Short-Term Debt	322	978	1 505	1 450	1 650	2 500	2 150	3 150	2 800	0	1 450	1 000	3 000	3 000	0	0	0	0	0
Current Portion of Long-Term Debt	55	33	90	1 008	789	774	579	402	904	268	261	339	996	907	978	10 114	4 489	20 229	145
Other Current Liabilities	65	129	153	297	243	576	669	464	607	729	994	6 547	9 505	10 094	3 415	2 383	28 202	11 886	641
Total Current Liabilities	569	1 347	1 990	3 001	3 028	3 984	3 781	4 183	4 728	1 170	3 268	8 106	13 822	14 167	4 675	12 704	33 254	32 218	786
Long-Term Debt	200	756	665	1 972	2 332	1 858	5 914	2 732	396	13 152	1 747	1 548	552	225	14 090	174	16 128	286	258
Deferred Income Tax	0	0	0	56	59	0	0	0	0	0	0	0	0	0	0	0	0	1 565	84
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	53	54	55	0	0	0	0
Other Liabilities	242	352	443	517	578	729	719	801	599	690	914	802	958	1 258	5 248	2 279	2 634	709	752
Total Liabilities	1 011 N/A	2 455 +143%	3 099 +26%	5 546 +79%	5 997 +8%	6 571 +10%	10 414 +58%	7 716 -26%	5 723 -26%	15 012 +162%	5 928 -61%	10 456 +76%	15 385 +47%	15 704 +2%	24 068 +53%	15 157 -37%	52 016 +243%	34 777 -33%	1 880 -95%
Equity
Common Stock	3 980	3 980	3 980	3 980	4 332	4 332	4 582	4 660	6 985	6 985	7 519	7 729	7 729	7 729	15 988	16 575	16 898	17 075	17 075
Retained Earnings	1 333	949	822	758	448	870	1 246	174	611	618	2 269	1 679	17 449	8 645	11 682	3 097	12 733	18 549	48 680
Additional Paid In Capital	1 101	1 101	1 101	1 161	2 290	2 290	5 118	6 095	8 895	11 242	24 151	41 030	41 030	41 030	61 622	66 737	72 604	79 978	39 978
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	41	0	324	0	0	0	0	0	0	0
Treasury Stock	0	0	0	0	0	0	0	0	6	498	498	1 967	1 967	1 967	1 967	1 967	1 967	10 960	10 960
Other Equity	0	0	0	0	0	0	942	1 000	1 000	1 000	1 000	1 002	901	945	1 001	938	1 082	1 538	1 961
Total Equity	3 747 N/A	4 132 +10%	4 258 +3%	4 383 +3%	7 069 +61%	7 491 +6%	10 004 +34%	11 929 +19%	17 484 +47%	19 389 +11%	34 442 +78%	49 150 +43%	30 245 -38%	39 092 +29%	64 964 +66%	85 379 +31%	101 349 +19%	106 181 +5%	96 734 -9%
Total Liabilities & Equity	4 758 N/A	6 587 +38%	7 357 +12%	9 929 +35%	13 066 +32%	14 062 +8%	20 418 +45%	19 645 -4%	23 207 +18%	34 400 +48%	40 370 +17%	59 606 +48%	45 630 -23%	54 796 +20%	89 032 +62%	100 536 +13%	153 365 +53%	140 959 -8%	98 615 -30%
Shares Outstanding
Common Shares Outstanding	21	21	21	21	23	23	23	24	28	28	30	30	30	30	30	33	34	33	33
Preferred Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2	0	0	0	0

Income Statement Balance Sheet Cash Flow Statement

iNtRON Biotechnology Inc
KOSDAQ:048530

Balance Sheet

Balance Sheet Decomposition
iNtRON Biotechnology Inc

Balance Sheet
iNtRON Biotechnology Inc

See Also

Company

Help

Tools

Stocks

iNtRON Biotechnology Inc KOSDAQ:048530

Balance Sheet

Balance Sheet Decomposition iNtRON Biotechnology Inc

Balance Sheet iNtRON Biotechnology Inc

See Also

Company

Help

Tools

Stocks

iNtRON Biotechnology Inc
KOSDAQ:048530

Balance Sheet Decomposition
iNtRON Biotechnology Inc

Balance Sheet
iNtRON Biotechnology Inc